Your Health Insurer Shouldn’t Dictate Treatments, Docs Say
As cost controls tighten, doctors and AI are pressing to restore clinician-led care. Investors are watching insurers’...
Timing matters: restructuring is best when income changes or spending diverges from goals.
16,677 articlesAs cost controls tighten, doctors and AI are pressing to restore clinician-led care. Investors are watching insurers’...
New student loan rules take effect on July 1, redefining borrowing limits and repayment options for millions of borro...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
In June, Netflix faced a sharp pullback as investors weighed slowing subscriber growth against rising content costs a...
The AI spending spree has some investors on edge. This guide explains why three big tech leaders may weather the stor...
Even with a stunning 19x profit surge, Samsung's stock slipped. This article breaks down why the market reacted this ...
BlackRock just became first to hit a historic $15 trillion in assets under management. This milestone signals scale, ...
A closer look at how Netflix blends AI-enabled production with patient capital. This isn't a new trick—it's a 25-year...
The monthly nonfarm payrolls report is a big market event, but it can mislead if you lean on it without guarding agai...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A data center spending surge across AI giants is reshaping markets. This article explains how a single company could ...
Investors are eyeing Life Time's Q4 2025 earnings to gauge membership momentum, pricing discipline, and growth strate...